Metabolic health across generations: preventing and controlling diabetes in the modern era

Diabetes mellitus constitutes an escalating global metabolic crisis impacting individuals across all age groups, from early childhood to adulthood. Contemporary diabetes care necessitates a paradigm shift from episodic glycemic management to the promotion of sustained metabolic health throughout the lifespan. This presentation examines an integrative, generation-spanning framework for the prevention and management of diabetes through coordinated public health, clinical medicine, and precision medicine strategies.

Early life determinants, such as genetic susceptibility, intrauterine metabolic programming, childhood obesity, and lifestyle transitions, are critical in the development of both Type 1 and Type 2 diabetes. Consequently, preventive strategies must commence with risk identification, nutritional interventions, and behavioral modifications during childhood and adolescence. In adults, metabolic syndrome, insulin resistance, and β-cell dysfunction exacerbate disease progression and elevate cardiovascular morbidity. The focus is on early metabolic screening, individualized pharmacotherapy, and comprehensive risk reduction.

Recent advancements in endocrinology and metabolic medicine, including incretin-based therapies, SGLT2 inhibitors, continuous glucose monitoring systems, and digital health platforms, have markedly transformed glycemic control and long-term outcomes. These innovations facilitate precision-based treatment models that integrate genomics, metabolic biomarkers, lifestyle analytics, and patient-centered care pathways. Additionally, special attention is given to gestational diabetes, intergenerational metabolic transmission, and the prevention of microvascular and macrovascular complications.

This presentation also underscores the influence of inflammation, gut microbiota modulation, and epigenetic factors in shaping metabolic health trajectories. By bridging prevention science with advanced therapeutic control, this lifespan approach emphasizes sustainable, equitable, and interdisciplinary strategies for diabetes management.

A generational perspective on metabolic health not only enhances individual outcomes but also fortifies public health systems, ensuring long-term diabetes control in an increasingly urbanized and aging global population.

Dr. Souravh Bais is a Professor and Research Coordinator in Pharmaceutical Sciences at Sage University, India. His research focuses on metabolic disorders, advanced drug delivery systems, and translational therapeutic strategies. He actively contributes to interdisciplinary research initiatives and has guided multiple research projects in pharmaceutical and biomedical sciences. His academic work emphasizes integrating preventive medicine, precision pharmacotherapy, and innovative healthcare approaches to improve long-term metabolic health outcomes. He published more than 65 research articles and books in international repute and he is a member of editorial board in very renowned journals.